Ascendis Pharma A/SASNDNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+101.0%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+101.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
8.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$98.52M+122.6%
2024$44.26M-0.3%
2023$44.40M+265.8%
2022$12.14M+244.5%
2021$3.52M-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-